Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid

Details for Australian Patent Application No. 2006331019 (hide)

International Classifications

Event Publications

18 December 2008 Section 223 Application Allowed

Abiogen Pharma S.p.a. The time in which to enter the National Phase has been extended to 29 Sep 2008. Address for service in Australia - Griffith Hack Level 19 109 St Georges Terrace Perth WA 6000 2007

8 January 2009 PCT application entered the National Phase

PCT publication WO2007/073921 Priority application(s): WO2007/073921

22 January 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 23 Sep 2008 2007

22 March 2012 Application Accepted

Published as AU-B-2006331019

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.